Novyra Pharmachem Limited
BSE: NOVYRA · Tea & Coffee · sector
₹8.50BSE close 2026-10-13
Key numbers
Market cap₹5 cr
Price₹8.50
52w high / low₹11 / ₹8
P/E1.0xSector median 8.9x
P/B9.1xSector median 0.7x
Book value₹0.9
Dividend yield–Sector median 0.86%
ROE-166.3%Sector median 3.7%
ROCE-906.7%Sector median 5.0%
OPM-286.8%Sector median 6.9%
Debt / equity0.00xSector median 0.22x
EV/EBITDA–Sector median 14.1x
Interest cover–
Current ratio0.83x
Sales growth 3y-11.4%Sector median -1.6%
Profit growth 3y–Sector median +9.0%
PEG0.00x
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 21 companies in Tea & Coffee (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Net loss in 5 of the last 6 quarters.
- No dividend in the last 5 financial years.
- Price ₹8.50 on 2026-10-13: -20.3% from the 52-week high, 0.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹16.55 · low ₹5.90
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 2 |
| EBITDA | -0 | -0 | 0 | 0 | -5 | -0 |
| OPM % | – | – | 33.3% | – | -5,330.0% | -1.2% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -0 | -0 | 0 | -0 | -5 | -0 |
| EPS (₹) | 0.08 | 0.03 | 0.00 | 0.02 | 8.43 | 0.03 |
| Revenue YoY | – | – | ||||
| Profit YoY | – | – |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | – | 0 | 0 | 2 |
| EBITDA | -0 | 0 | -0 | -0 | -5 | -5 |
| Net profit | 0 | 0 | -0 | -0 | -5 | -5 |
| EPS (₹) | – | 0.02 | -0.03 | 0.10 | 8.49 | 8.48 |
| Revenue growth | 0.0% | – | – | – | – | |
| Profit growth | – | -1,700.0% | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -11.4% | – | – |
| Net profit | – | – | – |
| EPS | +651.6% | – | – |
| Share price | – | – (2y) | – |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 6 | 1 |
| Borrowings | 0 | 0 |
| Cash & equivalents | 0 | 0 |
| Total assets | 6 | 1 |
| Fixed assets | 5 | 1 |
| Capital work in progress | 0 | – |
| Investments | 0 | 0 |
| Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Payables | 0 | 1 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | -0 | -4 |
| Cash from investing | 0 | 4 |
| Cash from financing | 0 | -0 |
| Capex | 0 | 0 |
| Free cash flow | -0 | -4 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | -1.1% | -907.6% |
| ROCE % | -1.1% | -907.6% |
| Debtor days | – | 38 |
| Inventory days | – | 0 |
| Payable days | – | 3,030 |
| Cash conversion cycle (days) | – | -2,992 |
| Working capital days | – | -520 |
Peers in Tea & Coffee
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TATACONSUM | ₹92,676 cr | 56.7x | 4.2x | 7.8% | 10.2% | 13.8% | +13.8% | 0.88% |
| CCL | ₹12,060 cr | 26.1x | 4.5x | 19.4% | 16.5% | 16.7% | +29.1% | 0.86% |
| VINCOFE | ₹2,148 cr | 27.2x | 3.8x | 18.1% | 16.0% | 18.5% | – | 0.06% |
| ANDREWYU | ₹1,074 cr | 25.9x | 3.3x | -12.5% | -13.1% | -27.0% | -7.6% | – |
| MCLEODRUSS | ₹478 cr | – | – | – | -14.2% | -12.6% | -5.5% | – |
| GOODRICKE | ₹456 cr | 3.8x | 1.5x | 22.0% | 21.3% | 8.4% | -3.2% | 0.02% |
| JAYSREETEA | ₹229 cr | – | 0.6x | -5.4% | 1.7% | 2.6% | +4.6% | 0.64% |
| GILLANDERS | ₹208 cr | 11.9x | 0.8x | 6.9% | 7.9% | 6.9% | -1.4% | – |
| NEAGI | ₹194 cr | 5.3x | 0.6x | 11.7% | 11.6% | 151.6% | +0.7% | 0.96% |
| NOVYRA | ₹5 cr | 1.0x | 9.1x | -166.3% | -906.7% | -286.8% | -11.4% | – |
Business segments (2026-06-30)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Pharma | ₹2 cr | 100.0% | ₹0 cr | 0.7% |
| Real estate | ₹0 cr | – | ₹0 cr | – |
| Tea estate | ₹0 cr | – | ₹0 cr | – |
| Unllocable | ₹0 cr | – | ₹0 cr | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Fast Moving Consumer Goods |
| Industry | Tea & Coffee |
| Sub-industry | Tea & Coffee |
| Symbol | NOVYRA |
| BSE code | 519353 |
| ISIN | INE856E01019 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-13.